FDA Inspection 1292766 — Matthew P. Sweet, MD

Matthew P. Sweet, MD — FEI 3040979765

The FDA completed an inspection of Matthew P. Sweet, MD on Nov 21, 2025 in Seattle, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Nov 21, 2025
Fiscal Year
2026
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Seattle, WA (United States)

Additional details

Clinical Investigator (CI)

Citations

IDCFRDescription
1450521 CFR 812.140(a)(3)Investigator's subject records inadequate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.